Home News 3rd Annual Advances in Immuno-Oncology Congress 2018

3rd Annual Advances in Immuno-Oncology Congress 2018

Event details

Event date

May 24, 2018 - May 25, 2018

Event location

99 City Road Conference Centre, London

Aquila are sponsors of Oxford Global’s 3rd Annual Advances in Immuno-Oncology Congress in London 24th-25th May 2018.


If you would like to find out more about our Immunology, Immuno-Oncology or Specialist Histology services, please come and talk to Louise Welch (BD & Marketing), Dawn Lyster (Scientific Program and Quality Manager) and Professor Steve Anderton (Group Head of Translational Biology) at Stand 11.

Professor Steve Anderton will be presenting our latest capabilities in Stream 1 at 9am Friday 25th May.

We are also presenting a poster “Biomarker Detection Using a Mixed Multiplex Approach” , showcasing our specialist multiplex histology services.

To organise a meeting with any member of the team in London, please get in touch.

The 3rd Annual Advances in Immuno-Oncology Congress focuses on key developments in Immuno-Oncology with specific reference to the discovery of therapeutic areas, pre-clinical and clinical studies. Click here to Find out more about the 3rd Annual Advances in Immuno-Oncology Congress.

For conference updates from Aquila, connect with us on LinkedIn and Twitter.


Immuno-oncology is an exciting and progressing area of research that uses manipulation of the immune system to successfully target cancer.


AWe offer a range of routine through to advanced histological techniques for specialised projects, including tissue processing to wax, single and multiplex immunohistochemistry (IHC)/ immunofluorescence...